Legeviten > Onkologi
UPDATES ON PROPANCS UPCOMING GOALS AND THEIR LEAD PRODUCT.
Les mer »
Over the last few months I am sure youve heard more and more regarding PPCH and their latest developments in the fight against pancreatic cancer.
(www.digitalproducer.com) |
Likeverdige helsetjenester for eldre?
Les mer »
Torsdag 15.juni lanseres det fjerde helseatlaset på www.helseatlas.no . Det nye atlaset omhandler variasjon i bruk av helsetjenester til eldre.
(Helse Nord RHF) |
Chondrosarcoma - Pipeline Review, H1 2017.
Les mer »
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Pipeline Review, H1 2017, provides an overview of the Chondrosarcoma pipeline landscape.
(www.digitalproducer.com) |
Another CDK4/6 Inhibitor Boosts PFS in Breast Cancer.
Les mer »
Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease.
(MedPage Today) |
OncoBreak: Amazon Drug Biz; Second Opinions; Sex During Chemo.
Les mer »
News, features, and commentary about cancer-related issues.
(MedPage Today) |
Watch-and-Wait OK in Sentinel Node Positive Melanoma.
Les mer »
Earn Free CME Credits by reading the latest medical news in your specialty.
(MedPage Today) |
08/06-2017 09:29:44: Isofol presenterar på Småbolagsdagen 12 juni 2017.
Les mer »
Isofol Medical AB meddelar att VD Anders Rabbe kommer under Småbolagsdagen den 12 juni presentera Isofol samt den senaste utvecklingen av bolaget. Evenemanget websänds live på www.smabolagsdagen.net.
(Netfonds) |
HistoSonics Technology's Exciting Preclinical Results to be Presented at the World Conference on Interventional Oncology 2017.
Les mer »
Company Also Hires Two Medtech Executives to Fill Key Roles.
(www.digitalproducer.com) |
No Survival Benefit with Node Dissection in Ovarian Ca.
Les mer »
Macroscopic complete resection drives outcomes.
(MedPage Today) |
Neuer Ansatz der Krebstherapie: Medikamente gegen Mutationen.
Les mer »
Krebsnest. Die mikroskopische Aufnahme zeigt gestreute Brustkrebszellen in einem Lymphknoten .
(www.tagesspiegel.de) |
07/06-2017 18:01:11: Accepted abstract by ICML with updated results from Phase 1/2 trial of Betalutin® in NHL is now available on-line.
Les mer »
An updated dataset on 59 patients and 47 patients will be presented in a poster at the meeting on 15 June by Dr.
(Netfonds) |
Invasive Bladder Cancer: Surgery Not Always the Best Option.
Les mer »
Radiation-based management offers equally good survival outcomes.
(MedPage Today) |
Two Anti-HER2 Drugs Slightly Better Than One.
Les mer »
Patient selection key to addition of pertuzumab to trastuzumab.
(MedPage Today) |
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers.
Les mer »
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers.
(inpublic.globenewswire.com) |
New Standard for ALK-Positive NSCLC.
Les mer »
Dramatic PFS, CNS benefits with alectinib.
(MedPage Today) |
Aptose Biosciences Announces Results of Annual Meeting of Shareholders.
Les mer »
APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the voting results from the Companys annual meeting of shareholders held today, June 6, 2017 (the ?Meeting).
(www.digitalproducer.com) |
Nytt legemiddel forsinket aggressiv lungekreft.
Les mer »
Ny type behandling reduserte ifølge forskere forløpet av en aggressiv form for lungekreft i omtrent to år, eller omtrent tre ganger så lenge som standardbehandling.
(ABC Nyheter) |
Genomic Testing Helps Cancer Patients -- When Results are Used.
Les mer »
Also, liquid biopsy can ID drug-responsive tumors.
(MedPage Today) |
Dacomitinib Sets PFS Record in Phase III NSCLC Trial.
Les mer »
Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy.
(MedPage Today) |
Disputas: Jill Brook Hervik - Onkologi.
Les mer »
Fysioterapeut Jill Brook Hervik ved Institutt for klinisk medisin vil forsvare sin avhandling for graden doctor philosophiae: Acupuncture for the treatment of hot flashes in breast cancer patients.
(Universitetet i Oslo) |
CAR T Cells Drive Outcomes in MM.
Les mer »
Studies show promise for precision immunotherapy.
(MedPage Today) |
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma.
Les mer »
Outcomes improved with nivolumab alone or with impilimumab in pretreated patients.
(MedPage Today) |
Novartis announces clinical collaboration with Bristol-Myers Squibb to evaluate potential treatments in metastatic colorectal cancer.
Les mer »
Collaboration expands upon existing clinical investigation of Opdivo combination with Novartis investigational and marketed therapies.
(inpublic.globenewswire.com) |
Trastuzumab Copycat Has Similar Efficacy.
Les mer »
Phase III trial compared substances in early-stage breast cancer.
(MedPage Today) |
Advanced Ca Patients Benefit from Online Symptom Reports.
Les mer »
Patient-reported outcomes tied to increased survival.
(MedPage Today) |
Big Win for PARP Inhibitor in Breast Cancer.
Les mer »
PFS boost for HER2-negative, BRCA-mutated disease.
(MedPage Today) |
Pain Shouldn't Be Part of Kids' Cancer Treatment.
Les mer »
Must address young patients' suffering from the start of care.
(MedPage Today) |
|Om Viddi.no | Kontakt oss på support (a) viddi.no | Copyright® - 2006 Viddinews AS |